dr. mohammad jahanzeb on neratinib and trastuzumab in her2-positive breast cancer
Published 8 years ago • 302 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
2:18
use of neratinib in her2-positive breast cancer
-
2:06
dr. jahanzeb on the aphinity and extenet trials in breast cancer
-
1:42
treatment landscape for her2-positive breast cancer
-
2:51
breast cancer: extended adjuvant therapy and cost factors
-
2:09
adjuvant therapy data for her2-positive breast cancer
-
2:35
dr. jahanzeb on overcoming her2 resistance in breast cancer
-
1:53
dr. jahanzeb discusses advancements in adjuvant her2 breast cancer
-
2:49
neratinib, trastuzumab fulvestrant for her2-mutant, hr , metastatic breast cancer
-
6:34
neoadjuvant therapy with neratinib plus trastuzumab in locally advanced her2-positive breast cancer
-
2:02
chemotherapy with adjuvant therapy in breast cancer
-
1:24
dr davis on the investigation of neratinib trastuzumab deruxtecan in advanced her2 solid tumors
-
2:48
the extenet study & management of her2 breast cancer
-
2:00
neratinib after trastuzumab-based adjuvant therapy in her 2 positive breast cancer (extenet)
-
3:27
her2 de novo mbc: neratinib vs lapatinib plus capecitabine
-
1:11
neratinib/t-dm1 doses recommended for phase ii trial in breast cancer
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
1:30
dr. hope rugo on trastuzumab biosimilar in her2-positive breast cancer
-
46:07
dr. mohamad jahanzeb's talk on breast cancer_august 28 2015_binaytara foundation
-
6:47
extended adjuvant therapy for her2-positive early breast cancer